Sun Pharma’s $12 Billion Organon Acquisition Bid: India’s Biggest Pharma Leap Yet?
In a development that could rewrite the playbook for Indian pharmaceutical companies on the global stage, Sun Pharmaceutical Industries is reportedly preparing a binding all cash offer of around $12 billion to acquire U.S. based Organon & Co.
